Mapping the way: identifying priority potential corridors for protected areas connectivity in Colombia
Perspectives in Ecology and Conservation · 2024-04 · 22 (2) · 156-166
DOI: 10.1016/j.pecon.2024.02.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Perspectives in Ecology and Conservation, 2024-04. Verfasst von Sara Pineda-Zapata und 4 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Our results have practical implications for decision-makers involved in conservation efforts. These findings can aid in identifying conservation priorities for existing protected areas and their surrounding forest habitats in Colombia. Additionally, we provided expert-based resistance values for different forest mammals that can be further used in other large scale connectivity analyses, including other countries where these species inhabit.
Zitieren
APA
Pineda-Zapata, S., González-Ávila, S., Armenteras, D., González-Delgado, T. M., & Morán-Ordoñez, A. (2024). Mapping the way: identifying priority potential corridors for protected areas connectivity in Colombia. Perspectives in Ecology and Conservation, 22(2), 156-166. https://doi.org/10.1016/j.pecon.2024.02.003
Vancouver
Pineda-Zapata S, González-Ávila S, Armenteras D, González-Delgado TM, Morán-Ordoñez A. Mapping the way: identifying priority potential corridors for protected areas connectivity in Colombia. Perspectives in Ecology and Conservation. 2024;22(2):156-166. doi:10.1016/j.pecon.2024.02.003
BibTeX
@article{PinedaZapata2024,
author = {Pineda-Zapata, Sara and González-Ávila, Sergio and Armenteras, Dolors and González-Delgado, Tania Marisol and Morán-Ordoñez, Alejandra},
title = {Mapping the way: identifying priority potential corridors for protected areas connectivity in Colombia},
journal = {Perspectives in Ecology and Conservation},
year = {2024},
volume = {22},
number = {2},
pages = {156--166},
doi = {10.1016/j.pecon.2024.02.003}
}
EUVIMED